BioCardia, Inc.

BioCardia, Inc.verified

BCDAW

Price:

$0.0061

Market Cap:

$11.92M

BioCardia, Inc., a clinical-stage regenerative medicine company, engages in development of cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP, an autologous mononuclear cell therapy system for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary disease. The company is also developing allogeneic cells therapeutic platform, an investigational culture expanded bone marrow derived mesenchymal cell therapy, which is in Phase I/II trial for the treatment of ischemic heart failure. In addition, it offers the Helix biotherapeutic delivery system that deliver...[Read more]

Industry

Biotechnology

IPO Date

2019-08-02

Stock Exchange

NASDAQ

Ticker

BCDAW

The Enterprise Value as of March 2025 (TTM) for BioCardia, Inc. (BCDAW) is 8.03M

According to BioCardia, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 8.03M. This represents a change of -9.90% compared to the average of 8.92M of the last 4 quarters.

BioCardia, Inc. (BCDAW) Historical Enterprise Value (quarterly & annually)

How has BCDAW Enterprise Value performed in the past?

The mean historical Enterprise Value of BioCardia, Inc. over the last ten years is 103.89M. The current 8.03M Enterprise Value has changed 673.32% with respect to the historical average. Over the past ten years (40 quarters), BCDAW's Enterprise Value was at its highest in in the December 2016 quarter at 1.10B. The Enterprise Value was at its lowest in in the September 2015 quarter at -9402092.80.

Quarterly (TTM)
Annual

Average

103.89M

Median

85.85M

Minimum

-3672515.90

Maximum

304.14M

20132014201520162017201820192020202120222023-105000000.000105.00M210.00M315.00MEnterprise Value

BioCardia, Inc. (BCDAW) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of BioCardia, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 45.56%

Maximum Annual Enterprise Value = 304.14M

Minimum Annual Increase = -8381.39%

Minimum Annual Enterprise Value = -3672515.90

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202314.28M-86.45%
2022105.38M20.49%
202187.46M3.82%
202084.24M45.56%
201957.87M-56.42%
2018132.80M-48.19%
2017256.34M-15.71%
2016304.14M-8381.39%
2015-3672515.90-4052.15%
201492.92K-101.04%

BioCardia, Inc. (BCDAW) Average Enterprise Value

How has BCDAW Enterprise Value performed in the past?

The current Enterprise Value of BioCardia, Inc. (BCDAW) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

69.04M

5-year avg

69.84M

10-year avg

103.89M

Today1Y3Y5Y10Y030.00M60.00M90.00M120.00MEnterprise Value

BioCardia, Inc. (BCDAW) Enterprise Value vs. Peers

How is BCDAW’s Enterprise Value compared to its peers?

BioCardia, Inc.’s Enterprise Value is greater than Artelo Biosciences, Inc. (-3675211.00), greater than Adial Pharmaceuticals, Inc. WT EXP 073123 (811.58K), less than Entera Bio Ltd. WT EXP 062723 (62.64M), greater than Xenetic Biosciences, Inc. (-1442070.00), greater than IMAC Holdings, Inc. (3.24M),

Build a custom stock screener for BioCardia, Inc. (BCDAW) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioCardia, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BioCardia, Inc. (BCDAW) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BioCardia, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is BioCardia, Inc.'s Enterprise Value?

What is the highest Enterprise Value for BioCardia, Inc. (BCDAW)?

What is the 3-year average Enterprise Value for BioCardia, Inc. (BCDAW)?

What is the 5-year average Enterprise Value for BioCardia, Inc. (BCDAW)?

How does the current Enterprise Value for BioCardia, Inc. (BCDAW) compare to its historical average?